It’s dominated TikTok and pop culture since Charlie XCX announced it was a brat summer after the release of her sixth album Brat back in June.
The concept, and the colour green, has been embraced by everyone from Kamala Harris to Gen Z and Gemma Collins has become the latest celebrity to hop on the trend.
The former TOWIE star, 43, looked sensational as she wowed in a strapless tulle bright green dress as it trailed along the floor.
Embracing her inner Bratz doll, Gemma took part in the social media trend as she transformed herself into a version of the cartoon doll in a similar dress.
She captioned the snap: ‘BRATZ. BRATZ SUMMER. It’s the WEEKEND ☀️ note to oneself …. HAVE FUN. One must always have FUN’.
Gemma Collins has hopped on the Brat summer trend as she wowed in bright green ball gown for her recent Instagram snap on Friday
She captioned the snap: ‘BRATZ. BRATZ SUMMER. It’s the WEEKEND ☀️ note to oneself …. HAVE FUN. One must always have FUN’
It’s dominated TikTok and pop culture since Charlie XCX announced it was a brat summer after the release of her sixth album Brat back in June
Charli’s album cover is slime green, which led to increased popularity of the shade, especially in fashion.
The Instagram account Data But Make it Fashion analysed the rise of green in fashion over the last year, crediting Charli, 32, and Colombian singer Feid for their contributions.
According to the social media account, the massive spike occurred from July 2023 to July 2024, making it 46 per cent more popular than this time last year, and now Gemma has hopped on the trend.
It comes after Gemma was reprimanded by Britain’s advertising watchdog for promoting a pulsating headset that claims to treat depression.
The advert posted to her Instagram, which has since been deleted, was said to ‘encourage people to take treatment for depression into their own hands’ instead of seeking medical help for the condition.
The star, who has 2.2million Instagram followers, was ordered by the Advertising Standards Authority (ASA) to remove the advert for the £400 device immediately.
In the clip, she is seen wearing the experimental gadget, called Flow Neuroscience AB, which sends mild electric shocks to the part of the brain responsible for regulating mood.
She goes on to state: ‘I’m off my depression tablets and this has been a real game changer for me. Flow actually works faster and better than antidepressants.
It comes after Gemma was reprimanded by Britain’s advertising watchdog for promoting a pulsating headset that claims to treat depression
The ad, which was posted in May last year, drew the ire of the Advertising Standards Agency (ASA) which said the post violated rules designed to stop ads from discouraging people from seeking treatment for medical conditions
‘It’s like having your own therapist in the comfort of your own home. You’re fully in control of your own treatment.’
Text accompanying the post also stated that the device ‘reduces depression in 88 per cent of people, according to Flow’s data.’
The ad drew the ire of the ASA when it was posted in May last year as it appeared to violate rules designed to stop ads discouraging people from seeking treatment for medical conditions.
The ASA disputed the sentences: ‘If you don’t have access to therapy or don’t want to be on antidepressants’ and ‘why not give it a go if you’re struggling with your mental health’.
This, the body said, suggested Flow could be used as an alternative to conventional treatment.
‘We considered that the reference to buying the device directly from the website added to the impression that consumers could bypass the medical consultation route,’ ASA ruled.
It added: ‘We considered that the claims were targeted at both those consumers who were weighing up treatment options at an early point in their illness and those who were currently receiving conventional medication or therapy for depression.’
Flow disputed ASA’s findings, highlighting how that the text accompanying the ad highlighted that people should consult their GP before thinking about using the device or changing their medication.
Collins herself endorsed Flow’s statement, the ASA documents state: ‘She believed the ad contained only personal observations and proven evidence and did not contain persuasive language.
‘The ad did not discourage essential treatment but, rather, flagged an alternative or supplementary one. ‘
But ASA said the text about consulting a GP was ‘insufficient’ to avoid its concerns.
‘We considered that this text did no more than suggest that consumers should arrange a consultation with a GP before starting to use the device,’ the ruling reads.
‘The text in the caption indicating that a GP should be consulted was insufficient to satisfy the requirement of the Code that ads must not offer treatment for depression unless that treatment was conducted under the supervision of a suitably qualified health professional.’
‘We considered that the ad trivialised the decision to come off antidepressants or not take them at all and encouraged people to take their treatment into their own hands.’
